“We are entering this next stage as our FDA-cleared portfolio continues to expand to support broader cardiac imaging workflows,” said Davidi Vortman, the company’s CEO and co-founder. | Read More in JPost.com – Business & Innovation | The Jerusalem Post
Norwegian FOR party and youth wing to participate in Oct. 7 demonstration in support of Hamas
Switzerland rejects asylum application from Iranian refugee pursuing Judaism
Canadian NDP leader slammed for Yom Kippur message claiming Jews failed ‘to stop ongoing genocide’
Bennett to Netanyahu: Declare Qatar an ‘enemy state’ at UN, ‘we’ll all back you’
Did Hitler kill his niece? New documents challenge alibi in Geli Raubal’s mysterious death
Seriously wounded West Bank ramming victim identified as Israeli ambassador’s son
Gaza Board of Peace unveils $2.45B rebuilding push: ‘Hamas ready to disarm’
MK Liberman’s proposal and halakha
Rubio: Iran is fundamentally misreading the American political system
‘We will not withdraw’: Katz fires back at Syrian President over Golan
After Yom Kippur, how can we remain silent about the Kotel?Israeli-led firm developing AI-guided cardiac sonography raises $24 million to expand in US marketNorwegian FOR party and youth wing to participate in Oct. 7 demonstration in support of Hamas